21 Citations (Scopus)

Abstract

Nanotechnology and personalized medicine are two of the most rapidly emerging areas of biomedical research, as well as two of the most promising technologies for improving health care and health outcomes. They are also rapidly converging in numerous current and future clinical applications. Examples include the use of nanotechnology for improved DNA sequencing and SNP analysis, the development of nano-therapeutics that can target specific cell and tissue types, biosensors for specific proteins and other molecules in vivo, and point-of-care molecular diagnostic devices enabled by nanotechnology. Nanotechnology offers many advantages for personalized medicine applications, including a size that matches the scale of the molecular substrates of personalized medicine, an increased sensitivity in detecting and binding with target molecules, and flexibility in the design and function of therapeutics and diagnostics at the nano scale. Yet, at the same time, the utilization of nanotechnology in personalized medicine may create uncertainties or risk relating to potential toxicity. In addition to describing the scientific and technical opportunities and challenges in applying nanotechnology to personalized medicine, this article also addresses some of the policy, legal and ethical issues raised by the convergence of nanotechnology and personalized medicine.

Original languageEnglish (US)
Pages (from-to)231-237
Number of pages7
JournalCurrent Pharmacogenomics and Personalized Medicine
Volume7
Issue number4
StatePublished - Dec 2009

Fingerprint

Precision Medicine
Nanotechnology
Point-of-Care Systems
Biomedical Technology
Molecular Pathology
Biosensing Techniques
DNA Sequence Analysis
Ethics
Uncertainty
Single Nucleotide Polymorphism
Biomedical Research
Equipment and Supplies
Health
Therapeutics

Keywords

  • Medical devices
  • Nanomedicine
  • Nanotechnology
  • Personalized medicine
  • Pharmaceuticals

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Pharmacology
  • Molecular Biology
  • Genetics(clinical)

Cite this

Small is beautiful : What can nanotechnology do for personalized medicine? / Marchant, Gary.

In: Current Pharmacogenomics and Personalized Medicine, Vol. 7, No. 4, 12.2009, p. 231-237.

Research output: Contribution to journalArticle

@article{8bc7f12b6df347e7b78c54a52007e756,
title = "Small is beautiful: What can nanotechnology do for personalized medicine?",
abstract = "Nanotechnology and personalized medicine are two of the most rapidly emerging areas of biomedical research, as well as two of the most promising technologies for improving health care and health outcomes. They are also rapidly converging in numerous current and future clinical applications. Examples include the use of nanotechnology for improved DNA sequencing and SNP analysis, the development of nano-therapeutics that can target specific cell and tissue types, biosensors for specific proteins and other molecules in vivo, and point-of-care molecular diagnostic devices enabled by nanotechnology. Nanotechnology offers many advantages for personalized medicine applications, including a size that matches the scale of the molecular substrates of personalized medicine, an increased sensitivity in detecting and binding with target molecules, and flexibility in the design and function of therapeutics and diagnostics at the nano scale. Yet, at the same time, the utilization of nanotechnology in personalized medicine may create uncertainties or risk relating to potential toxicity. In addition to describing the scientific and technical opportunities and challenges in applying nanotechnology to personalized medicine, this article also addresses some of the policy, legal and ethical issues raised by the convergence of nanotechnology and personalized medicine.",
keywords = "Medical devices, Nanomedicine, Nanotechnology, Personalized medicine, Pharmaceuticals",
author = "Gary Marchant",
year = "2009",
month = "12",
language = "English (US)",
volume = "7",
pages = "231--237",
journal = "Current Pharmacogenomics and Personalized Medicine",
issn = "1875-6921",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Small is beautiful

T2 - What can nanotechnology do for personalized medicine?

AU - Marchant, Gary

PY - 2009/12

Y1 - 2009/12

N2 - Nanotechnology and personalized medicine are two of the most rapidly emerging areas of biomedical research, as well as two of the most promising technologies for improving health care and health outcomes. They are also rapidly converging in numerous current and future clinical applications. Examples include the use of nanotechnology for improved DNA sequencing and SNP analysis, the development of nano-therapeutics that can target specific cell and tissue types, biosensors for specific proteins and other molecules in vivo, and point-of-care molecular diagnostic devices enabled by nanotechnology. Nanotechnology offers many advantages for personalized medicine applications, including a size that matches the scale of the molecular substrates of personalized medicine, an increased sensitivity in detecting and binding with target molecules, and flexibility in the design and function of therapeutics and diagnostics at the nano scale. Yet, at the same time, the utilization of nanotechnology in personalized medicine may create uncertainties or risk relating to potential toxicity. In addition to describing the scientific and technical opportunities and challenges in applying nanotechnology to personalized medicine, this article also addresses some of the policy, legal and ethical issues raised by the convergence of nanotechnology and personalized medicine.

AB - Nanotechnology and personalized medicine are two of the most rapidly emerging areas of biomedical research, as well as two of the most promising technologies for improving health care and health outcomes. They are also rapidly converging in numerous current and future clinical applications. Examples include the use of nanotechnology for improved DNA sequencing and SNP analysis, the development of nano-therapeutics that can target specific cell and tissue types, biosensors for specific proteins and other molecules in vivo, and point-of-care molecular diagnostic devices enabled by nanotechnology. Nanotechnology offers many advantages for personalized medicine applications, including a size that matches the scale of the molecular substrates of personalized medicine, an increased sensitivity in detecting and binding with target molecules, and flexibility in the design and function of therapeutics and diagnostics at the nano scale. Yet, at the same time, the utilization of nanotechnology in personalized medicine may create uncertainties or risk relating to potential toxicity. In addition to describing the scientific and technical opportunities and challenges in applying nanotechnology to personalized medicine, this article also addresses some of the policy, legal and ethical issues raised by the convergence of nanotechnology and personalized medicine.

KW - Medical devices

KW - Nanomedicine

KW - Nanotechnology

KW - Personalized medicine

KW - Pharmaceuticals

UR - http://www.scopus.com/inward/record.url?scp=73649131234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649131234&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 231

EP - 237

JO - Current Pharmacogenomics and Personalized Medicine

JF - Current Pharmacogenomics and Personalized Medicine

SN - 1875-6921

IS - 4

ER -